eccogene glp-1 Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China GLP-1 Analogues Market Size to
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

-agonists-market-key-insight.png)






















